Aligos Therapeutics, Inc. (ALGS) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 3 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for ALGS is $20.00, representing a +133.9% upside from the current price of $8.55. Price targets range from a low of $20.00 to a high of $20.00.
